EXELIXIS INC.

Genomics-based drug discovery company

1851 Harbor Bay Parkway Alameda CA 94502, Alameda, CA  ·  JAMES FENTON

Filings
32
Clients
1
Total Income
Years Active
2019–2026

Filings

Year Client Period Income Expenses Doc
2026 EXELIXIS INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$520,000
2025 EXELIXIS INC. 3rd Quarter (July 1 - Sep 30)
AMENDED
$510,000
2025 EXELIXIS INC. 4th Quarter (Oct 1 - Dec 31)
AMENDED
$510,000
2025 EXELIXIS INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$500,000
2025 EXELIXIS INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$500,000
2025 EXELIXIS INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$480,000
2025 EXELIXIS INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$460,000
2024 EXELIXIS INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$460,000
2024 EXELIXIS INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$460,000
2024 EXELIXIS INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$460,000
Page 1 of 4  ·  32 filings Next

Clients Represented

ClientFilingsTotal Income
EXELIXIS INC. 32

Lobbyists

NameDisclosed Prior Position
JAMES M. FENTON Chief of Staff, Leg. Director & Staff Assist. to Sen. Chris Dodd, and Prof. Staff Member of Senate HELP Subcommittee on…
ERIN HERMANCE Sr. Legislative Director, Rep. John Katko (2015-2017); and Staff Assistant, House Speaker John Boehner (2011).
JARED DANIEL MICHAUD